Porcine Immunoglobulin G

Shipped with Ice Packs
In Stock

Description

Subclasses and Functional Heterogeneity

Pigs possess six IgG subclasses, though recent studies identify eight engineered variants (IgG1, IgG2a, IgG2b, IgG2c, IgG3, IgG4, IgG5b, IgG5c) derived from monoclonal antibodies. Functional disparities among these subclasses are well-documented:

SubclassKey FunctionsBinding to Immune Cells
IgG1CDCC, ADCC, ADCP; strong complement activationMonocytes, macrophages, NK cells
IgG2aModerate CDCC/ADCC; efficient complement activationSimilar to IgG1
IgG2bComparable to IgG1/IgG2a; variable ADCC efficacyMonocytes, macrophages
IgG2cHigh ADCC/ADCP activity; robust FcγR bindingNK cells, phagocytes
IgG4Complement activation; weaker ADCC than IgG1/IgG2aMonocytes, macrophages
IgG3Limited Fc-mediated functions; binds monocytes/macrophages weaklyMonocytes, macrophages (weak)
IgG5bPoor functional activity; weak FcγR bindingMinimal
IgG5cSimilar to IgG5b; negligible effector functionsMinimal

Data synthesized from

Genomic Organization
Functionally analogous subclasses (e.g., IgG1, IgG2a, IgG2b, IgG2c, IgG4) cluster together in the porcine genome, suggesting evolutionary conservation of effector roles .

Fc-Mediated Functions and Mechanisms

The Fc domain governs IgG’s ability to engage immune effectors:

Antibody-Dependent Cellular Cytotoxicity (ADCC)

IgG1, IgG2a, IgG2b, IgG2c, and IgG4 mediate ADCC by binding Fcγ receptors on NK cells and neutrophils, triggering cytotoxic granule release. For example, IgG1 exhibits robust ADCC against influenza-infected cells in pig models .

Antibody-Dependent Cellular Phagocytosis (ADCP)

IgG2c and IgG1 promote phagocytosis by opsonizing pathogens, enabling macrophages to engulf and destroy them. IgG2c shows superior ADCP efficiency compared to other subclasses .

Complement-Dependent Cellular Cytotoxicity (CDCC)

IgG1, IgG2a, and IgG2b activate the classical complement pathway, leading to target cell lysis. IgG2a demonstrates higher CDCC efficacy than IgG1 in porcine models .

IgG3 Limitations
IgG3 exhibits minimal Fc-mediated activity except for weak binding to monocytes/macrophages. This contrasts with predictions of high complement activation based on sequence homology, highlighting the need for in vivo validation .

N-Glycosylation and Immune Maturation

Postnatal changes in N-glycosylation influence IgG’s effector functions. A study analyzing pigs from birth to five months revealed:

AgeN-Glycan Composition (Key Changes)Functional Implications
7–26 daysHigh GlcNAc (61.4%), low Gal (15.7%)Maternal IgG (milk-derived); anti-inflammatory
26–28 daysIncreased Man (36.6%) and Gal (23.6%); reduced GlcNAc (39.8%)Weaning stress; pro-inflammatory shifts
150 daysLower Gal, higher GlcNAc; simpler glycans (e.g., Man5GlcNAc2)Endogenous IgG production; enhanced inflammatory responses

Data from

Developmental Significance
Maternal IgG (via milk) in neonates contains complex, anti-inflammatory glycans, while endogenous IgG in older pigs has simpler, pro-inflammatory structures. This shift aligns with post-weaning immune challenges in swine .

Biomedical Models

Pigs serve as a large-animal model for testing therapeutic antibodies due to physiological similarities to humans. Porcine IgG1 monoclonal antibodies (e.g., pb27) have demonstrated efficacy in reducing H1N1pdm09 virus shedding and lung pathology .

Diagnostic and Reagent Uses

  • Blocking Agents: Purified porcine IgG (e.g., Leinco’s AffiPure™) is used to block non-specific binding in flow cytometry and ELISA assays .

  • ELISA Kits: ALPCO’s porcine IgG ELISA quantifies IgG levels in plasma/serum, aiding in immune monitoring .

Agricultural Disease Management

IgG subclasses with strong ADCC/CDCC (e.g., IgG1, IgG2c) are candidates for passive immunization strategies against swine pathogens like African swine fever and porcine reproductive and respiratory syndrome (PRRS) .

Q&A

What Are the Primary IgG Subclasses in Pigs and Their Functional Characteristics?

Porcine IgG subclasses include IgG1, IgG2a, IgG2b, IgG2c, IgG3, IgG4, IgG5b, and IgG5c. These differ significantly in Fc-mediated effector functions:

SubclassComplement Activation (CDCC)Antibody-Dependent Cellular Cytotoxicity (ADCC)Antibody-Dependent Cellular Phagocytosis (ADCP)Binding to Immune Cells
IgG1Strong (Rabbit/Pig complement)High lytic activityHigh phagocytosisMonocytes, macrophages, NK cells
IgG2aStrongModerateModerateMonocytes, macrophages, NK cells
IgG2bStrongModerateModerateMonocytes, macrophages, NK cells
IgG2cStrongHighHighMonocytes, macrophages, NK cells
IgG3NoneWeak/no activityNoneMonocytes, macrophages (weak NK binding)
IgG4StrongHighHighMonocytes, macrophages, NK cells
IgG5bNoneWeakWeakLimited binding
IgG5cWeakVariableWeakLimited binding

Key Methodological Considerations:

  • Selection for Therapeutic Antibodies: Prioritize IgG1, IgG2a, IgG2b, IgG2c, or IgG4 for Fc-mediated effector functions. IgG3 and IgG5b are functionally limited .

  • Assay Design: Use cytokine-activated porcine NK cells (e.g., IL-2, IL-12, IL-18) for ADCC/ADCP assays, and rabbit/pig complement for CDCC .

How Do Cytokines Influence IgG Isotype Production in Pigs?

Cytokine-driven polarization of immune responses governs IgG subclass expression:

Cytokine TypeCytokines InvolvedIgG Subclass BiasMechanism
Type 1IFN-γ, IL-12IgG2 (cell-mediated immunity)Suppress IgG1 production
Type 2IL-4, IL-10IgG1 (antibody-mediated immunity)Enhance IgG1 secretion

Experimental Approaches:

  • In Vitro Studies: Culture porcine B cells with recombinant cytokines (e.g., rpIL-10, rpIFN-γ) to analyze IgG1/IgG2 ratios .

  • In Vivo Models: Use pathogens like Actinobacillus pleuropneumoniae to correlate IgG1:IgG2 ratios with protection .

What Methodologies Are Used to Characterize Porcine IgG-Binding Proteins?

To identify IgG-binding proteins (e.g., enolase), researchers employ:

A. Western Blotting

  • Resolve proteins (e.g., enolase, casein) via 12% SDS-PAGE.

  • Transfer to PVDF membranes and probe with porcine IgG (pIgG) or human IgG (hIgG) at 20 µg/ml.

  • Detect binding via HRP-conjugated Staphylococcal Protein A (SPA) .

B. Dot Blot Analysis

  • Spot recombinant proteins on PVDF membranes.

  • Block with 5% skim milk, then incubate with pIgG/hIgG.

  • Visualize binding using DAB .

Critical Controls:

  • Negative Controls: Use casein to exclude non-specific binding .

  • Validation: Confirm binding regions via N-terminal sequencing or mutagenesis.

How Do Genomic Organization and Evolution Shape Porcine IgG Subclass Functions?

Functionally similar subclasses cluster in the genome:

  • IgG1, IgG2a, IgG2b, IgG2c, IgG4: Grouped in a region associated with strong effector functions.

  • IgG3, IgG5b, IgG5c: Located in distinct regions with reduced functionality .

Bioinformatics Workflows:

  • Align porcine IGHG genes (e.g., IGHG1: AB699686) to identify homologs.

  • Use phylogenetic tools (e.g., RAxML) to infer subclass relationships.

  • Correlate genomic clustering with functional data (e.g., ADCC/CDCC assays) .

What Are Key Discrepancies Between In Vitro and In Vivo Data for Porcine IgG?

Example: IgG3’s role in newborns vs. adults:

  • In Vitro: No Fc-mediated functions (e.g., CD107a mobilization) .

  • In Vivo: High IgG3 expression in neonatal gut-associated lymphoid tissues (GALT) suggests pre-adaptive immunity .

Resolving Contradictions:

  • Epitope-Specificity: Validate in vivo efficacy with HA-sialic acid-binding antibodies .

  • Model Systems: Use pig models for influenza to assess therapeutic IgG subclasses (e.g., pb27 IgG1) .

How Should Researchers Select IgG Subclasses for Therapeutic Antibodies?

Decision Framework:

FactorRecommended SubclassRationale
NeutralizationIgG1, IgG2a, IgG2bHigh affinity to HA head epitopes
ADCC/ADCPIgG1, IgG2c, IgG4Strong NK cell activation
Complement ActivationIgG1, IgG2a, IgG2cEffective CDCC with pig/rabbit complement
Maternal TransferIgG3 (neonates)Elevated in late-term fetuses

Case Study: For anti-influenza antibodies, prioritize IgG1 for balanced neutralization and effector functions .

What Are Emerging Research Directions for Porcine IgG?

  • Optimizing Fc Functions: Engineer IgG subclasses (e.g., IgG3) to enhance effector activity.

  • Neonatal Immunity: Investigate IgG3’s role in pre-adaptive responses in piglets.

  • Cross-Species Therapeutics: Develop porcine mAbs for swine models to avoid anti-human responses .

Methodological Innovations:

  • Genome Editing: CRISPR/Cas9 to modify IGHG loci for subclass switching.

  • Single-Cell RNA-seq: Profile B-cell responses to pathogens like African swine fever virus.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.